Mak, A. (2022) “IL-17 Inhibitors and the Risk of Malignancy”, Canadian Dermatology Today. Toronto, Canada, 3(1), pp. 21–24. Available at: https://canadiandermatologytoday.com/article/view/3-1-mak (Accessed: 21 November 2024).